Skip to content

PilAm Go4Health Weight Loss Program to Prevent Heart Disease

Pilipino Americans Go4Health Weight Loss Program to Prevent Heart Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02290184
Enrollment
45
Registered
2014-11-13
Start date
2014-11-01
Completion date
2017-08-31
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 Diabetes

Keywords

Type 2 diabetes, cardiovascular disease prevention, weight loss lifestyle intervention, physical activity, diet, Filipinos

Brief summary

This is a pilot randomized controlled trial intervention to improve lifestyle behaviors (physical activity and health diet) for Filipino Americans with type 2 diabetes on metformin. If the PilAm Go4Health intervention demonstrates potential efficacy, it may identify effective intervention strategies to significantly reduce risks for heart disease risks (i.e., metabolic syndrome) in Filipino Americans.

Detailed description

Filipino Americans are the second largest Asian population and fastest growing racial group in the United States. They have one of the highest rates of insulin resistance (type 2 diabetes = T2DM) and central obesity (fat distributions primarily in the abdominal region). T2DM and central obesity are two of five major risk factors for metabolic syndrome that lead to cardiovascular disease and stroke. Key factors contributing to obesity and T2DM in Filipinos are their physical inactivity, and a diet high in fat and soda intake. However, there are very few research studies on improving health behaviors to reduce risks for metabolic syndrome in Filipino Americans. To help reduce the risk of developing metabolic syndrome in overweight/obese Filipino Americans with T2DM, the proposed project will test a culturally appropriate health behavior intervention program to reduce weight and waist circumference, through increasing physical activity, and lowering fat and sugar sweetened beverage intake. This intervention uses a mobile phone health app and social networking to encourage adherence to target health behaviors. The goals are to: 1. To assess feasibility and acceptability of the culturally appropriate PilAm Go4Health Weight Loss Program 2. To obtain preliminary estimates of the effect of the intervention on weight 3. To conduct post-program process evaluations too improve the intervention relevancy for the target population.

Interventions

BEHAVIORALPilAm Go4Health Weight-loss Program

This is a 3-month lifestyle intervention program promoting weight loss through physical activity and health diet using a mobile health application (app), pedometer to track daily step-counts, and social networking (in-person and virtual social networking through Facebook) to reduce risks for metabolic syndrome in Filipino Americans with type 2 diabetes on metformin. Subjects will be asked: 1) to use a mobile app diary every day to input their weight, and calories (food and drink intake) and 2) wear a pedometer everyday to monitor their physical activity (step-counts).

BEHAVIORALActive Control

This is a 3-month active control using a pedometer only without any education related to wt loss, physical activity, health eating, or tracking healthy behaviors

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

statistician has been masked from any subjects' personal and confidential information

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Self-identified as Filipino 2. Age \> 18 years 3. BMI for Asians \> 23 kg/m2 4. Physician diagnosed T2DM diabetes confirmed by clinical data (e.g. documentation of fasting blood glucose \>126 mg/dL or a positive oral glucose tolerance test (OGTT) \> 200 mg/dl, HbA1c \> 6.5%) 5. On metformin for T2DM 4\) waist circumference: men \> 40 inches, women \> 35 inches 6) Physically inactive - most leisure time spent without much physical activity 7) No cognitive impairment per the Mini-Cog test 8) has a mobile smart phone (iPhone 4s or above, or android phone) 9) English speaking. Only one member per household allowed to enroll in the study.

Exclusion criteria

1. Uncontrolled T2DM 2. Glucose metabolism associated disease (Cushing's syndrome, Acromegaly, and Pheochromocytoma currently under treatment, chronic pancreatitis), 2) Thyroid disease - sub-optimally treated 3. Known medical conditions or other physical problems needing a special exercise program (e.g., prior myocardial infarction, history of angioplasty or angina, admission for hospital evaluation of chest pain, use of nitroglycerin for angina, chronic obstructive pulmonary disease, or uncontrolled hypertension) 4. Recent acute coronary syndrome, congestive heart failure 5. Currently participating in a lifestyle modification program 6. Planning a trip outside of the US during the 6-month study period 7. Known eating disorder 8. Planning a surgery in the next 7-months 9. Taking long-term antibiotics (including HIV-related agents), anti-tuberculosis agents (except isoniazid alone as prophylaxis), or prescription weight-loss drugs

Design outcomes

Primary

MeasureTime frameDescription
Feasibility for Participant Enrollment and RetentionBaseline to 6-monthsAble to enroll at least 20 eligible participants per arm (measured by count), and retain at least 80% of enrolled participants in each arm

Secondary

MeasureTime frameDescription
Weight Change in KilogramsBaseline to 3 monthsweight change in kilograms over a 3 month period. Intervention group will have a significantly greater reduction in weight change compared to the active control from baseline to 3-months
Percent Change in Weight (kg) From Baseline and 3 MonthsBaseline to 3 months100 x change in weight (kg) at 3 months divided by weight (kg) at baseline. Intervention group will have a significantly greater reduction in % weight change compared to the active control from baseline to 3-months.
Change in Waist Circumferencebaseline to 3 monthsChange in waist circumference over time within groups

Countries

United States

Participant flow

Recruitment details

All potential participants are invited to complete a pre-telephone screening. Those who pass the pre-telephone screening are potentially eligible to participate in the study and invited to attend a screening baseline visit where they are asked to complete a physical exam, serum blood tests, and a 2 week run-in period.

Pre-assignment details

During the 2-week run-in, eligible participants are asked to wear Fitbit pedometer every day for 10 hours/day, take photos with their smart phone of each meal for 3 consecutive days, and email these photos to research study email. Those who pass the physical exam, serum lab test, and run-in period are then randomized to one of two study groups.

Participants by arm

ArmCount
Start With PilAm Go4Health Program
Baseline to 3-months this groups will start with the PilAm Go4Health Weight-loss Program lifestyle intervention. After 3 months this group will transition to a 3-month maintenance phase where they will continue to maintain the physical activity and healthy eating behaviors learned in the PilAm Go4Health Weight-loss Program lifestyle intervention and will complete the study for a total of 6 months. PilAm Go4Health Weight-loss Program: This is a 3-month lifestyle intervention program promoting weight loss through physical activity and health diet using a mobile health application (app), pedometer to track daily step-counts, and social networking (in-person and virtual social networking through Facebook) to reduce risks for metabolic syndrome in Filipino Americans with type 2 diabetes on metformin. Subjects will be asked: 1) to use a mobile app diary every day to input their weight, and calories (food and drink intake) and 2) wear a pedometer everyday to monitor physical activity
22
Start With Pedometer Only
In the first 3 months this groups will start with a pedometer only. After 3 months, this group will transition to receive the PilAm Go4Health Weight-loss Program lifestyle intervention for the next 3 month and will complete the study for a total of 6 months PilAm Go4Health Weight-loss Program: This is a 3-month lifestyle intervention program promoting weight loss through physical activity and health diet using a mobile health application (app), pedometer to track daily step-counts, and social networking (in-person and virtual social networking through Facebook) to reduce risks for metabolic syndrome in Filipino Americans with type 2 diabetes on metformin. Subjects will be asked: 1) to use a mobile app diary every day to input their weight, and calories (food and drink intake) and 2) wear a pedometer everyday to monitor their physical activity (step-counts).
23
Total45

Baseline characteristics

CharacteristicStart With PilAm Go4Health ProgramStart With Pedometer OnlyTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
22 Participants23 Participants45 Participants
Age, Continuous57.4 years
STANDARD_DEVIATION 9.8
57.7 years
STANDARD_DEVIATION 10
57.6 years
STANDARD_DEVIATION 9.8
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
22 Participants23 Participants45 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
22 Participants23 Participants45 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
United States
22 Participants23 Participants45 Participants
Sex: Female, Male
Female
14 Participants14 Participants28 Participants
Sex: Female, Male
Male
8 Participants9 Participants17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 220 / 23
other
Total, other adverse events
0 / 220 / 23
serious
Total, serious adverse events
0 / 220 / 23

Outcome results

Primary

Feasibility for Participant Enrollment and Retention

Able to enroll at least 20 eligible participants per arm (measured by count), and retain at least 80% of enrolled participants in each arm

Time frame: Baseline to 6-months

Population: Total number of enrolled participants in each arm who completed 6-month program divided by the total number of enrolled participants in each arm. Goal is to retain 80% of participants enrolled in each arm.

ArmMeasureValue (NUMBER)
Intervention / PilAm Go4Health ProgramFeasibility for Participant Enrollment and Retention22 percentage of participants retained
Active Control - Pedometer OnlyFeasibility for Participant Enrollment and Retention23 percentage of participants retained
Secondary

Change in Waist Circumference

Change in waist circumference over time within groups

Time frame: baseline to 3 months

Population: Multilevel regression used to analyze the within group change for waist circumference and cross-level interaction for between group change over time.

ArmMeasureValue (MEAN)
Intervention / PilAm Go4Health ProgramChange in Waist Circumference-2.5 centimeter
Active Control - Pedometer OnlyChange in Waist Circumference-0.16 centimeter
Comparison: Hypothesis: Intervention group will have a significantly greater reduction in waist-circumference (cm) compared to the Active Control from baseline to 3-months95% CI: [-4.5, -0.91]
Secondary

Percent Change in Weight (kg) From Baseline and 3 Months

100 x change in weight (kg) at 3 months divided by weight (kg) at baseline. Intervention group will have a significantly greater reduction in % weight change compared to the active control from baseline to 3-months.

Time frame: Baseline to 3 months

Population: Filipino American adults 18 years or older with overweight and Type 2 diabetes were randomized in a 1:1 ratio to either the Intervention or the Active Control group.

ArmMeasureValue (MEAN)
Intervention / PilAm Go4Health ProgramPercent Change in Weight (kg) From Baseline and 3 Months-2.9 percent change
Active Control - Pedometer OnlyPercent Change in Weight (kg) From Baseline and 3 Months-.28 percent change
Comparison: Hypothesis: Intervention group will have a significantly greater reduction in % weight change compared to the active control from baseline to 3-months0.05% CI: [-3.9, -1.4]
Secondary

Weight Change in Kilograms

weight change in kilograms over a 3 month period. Intervention group will have a significantly greater reduction in weight change compared to the active control from baseline to 3-months

Time frame: Baseline to 3 months

Population: English-speaking Filipino Americans adults 18 years or older with overweight and Type 2 diabetes were randomized in a 1:1 ratio to either the intervention or active control group.

ArmMeasureValue (MEAN)
Intervention / PilAm Go4Health ProgramWeight Change in Kilograms-2.1 kilogram
Active Control - Pedometer OnlyWeight Change in Kilograms-.12 kilogram
Comparison: Hypothesis: the intervention group will have a significantly greater reduction in weight (kg) compared to the active control from baseline to 3-months.0.05% CI: [-3, -1.1]

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026